Custom Stent-Graft aims to fix aortic aneurysms without open surgery

NCT ID NCT07611968

Recruiting now Disease control Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 14, 2026 · Updated 3 times

Summary

This study tests a stent-graft that doctors modify before use to treat complex aortic aneurysms. It involves 20 high-risk patients who cannot have standard open surgery. The goal is to see if the device is safe and prevents aneurysm growth or rupture.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Physician-Modified Terumo Treo Abdominal Stent-Graft System
What this could lead to: If successful, this could offer a less invasive treatment option for complex aortic aneurysms, reducing the need for open surgery.
What could go wrong: This is a small, early-stage study with only 20 participants, so results may not apply to everyone. There are risks like aneurysm rupture, stroke, or kidney failure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABDOMINAL AORTIC ANEURYSM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

abdominal aortic aneurysm aortic aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AORTIC ANEURYSM

Contacts and locations

Locations

Mayo Clinic
RECRUITING

Jacksonville, Florida, 32224, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.